Karen M Facey (Karen Facey)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 12

Top Topics

Health Promotion

Decision Making

Top Venues

International journal of technology assessment in health care

Journal of comparative effectiveness research

International journal of environmental research and public health

This page only lists publications with an associated author ORCID identifier.

Publications

Elena Nicod, Andrew J Lloyd, Thomas Morel, Michela Meregaglia, Sheela Upadhyaya, Amanda Whittal, Karen M Facey, Michael F Drummond
Improving Interpretation of Evidence Relating to Quality of Life in Health Technology Assessments of Rare Disease Treatments. The patient (2022)
Denis Horgan, Bettina Borisch, Ivana Cattaneo, Mark Caulfield, Arturo Chiti, Christine Chomienne, Amanda Cole, Karen M Facey, Allan Hackshaw, Minna Hendolin, Nadia Georges, Dipak Kalra, Birutė Tumienė, Martina von Meyenn
Factors Affecting Citizen Trust and Public Engagement Relating to the Generation and Use of Real-World Evidence in Healthcare. International journal of environmental research and public health 19 (3) (2022)
Wija Oortwijn, Donald Husereau, Julia Abelson, Edwine Barasa, Diana Beatriz S Bayani, Vania Canuto Santos, Anthony J Culyer, Karen M Facey, David Grainger, Katharina Kieslich, Daniel A Ollendorf, Andrés Pichon-Riviere, Lars Sandman, Valentina Strammiello, Yot Teerawattananon
Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force. International journal of technology assessment in health care 38 (1) (2022)
Gorana Capkun, Sorcha Corry, Oonagh Dowling, Fatemeh Asad Zadeh Vosta Kolaei, Shweta Takyar, Cláudia Furtado, Pall Jonsson, Diane Kleinermans, Laurie Lambert, Anja Schiel, Karen M Facey
Can we use existing guidance to support the development of robust real-world evidence for health technology assessment/payer decision-making? International journal of technology assessment in health care 38 (1) (2022)
Karen M Facey, Jaime Espín, Emma Kent, Angèl Link, Elena Nicod, Aisling O'Leary, Entela Xoxi, Inneke van de Vijver, Anna Zaremba, Tatyana Benisheva, Andrius Vagoras, Sheela Upadhyaya
Implementing Outcomes-Based Managed Entry Agreements for Rare Disease Treatments: Nusinersen and Tisagenlecleucel. PharmacoEconomics 39 (9) (2021)
Seamus Kent, Maximilian Salcher-Konrad, Stefania Boccia, Jacoline C Bouvy, Chiara de Waure, Jaime Espin, Karen M Facey, Mary Nguyen, Juan Carlos Rejon-Parrilla, Pall Jonsson
The use of nonrandomized evidence to estimate treatment effects in health technology assessment. Journal of comparative effectiveness research 10 (14) (2021)
Philip A Powell, Jill Carlton, Donna Rowen, John Brazier, Karen M Facey, Klair Bayley, Fleur Chandler, Josie Godfrey, Emily Crossley
Measuring What Matters: Little Evidence Supporting the Content Validity of EQ-5D in People with Duchenne Muscular Dystrophy and Their Caregivers. Medical decision making : an international journal of the Society for Medical Decision Making (2021)
Amanda Whittal, Elena Nicod, Mike Drummond, Karen M Facey
Examining the impact of different country processes for appraising rare disease treatments: a case study analysis. International journal of technology assessment in health care 37 (1) (2021)
Aline Silveira Silva, Karen M Facey, Stirling Bryan, Dayani Galato
A framework for action to improve patient and public involvement in health technology assessment. International journal of technology assessment in health care 38 (1) (2021)
Karen M Facey, Piia Rannanheimo, Laura Batchelor, Marine Borchardt, Jo de Cock
Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU-actions for stakeholders. International journal of technology assessment in health care (2020)
Karen M Facey, Nicola Bedlington, Sarah Berglas, Neil Bertelsen, Ann N V Single, Victoria Thomas
Putting Patients at the Centre of Healthcare: Progress and Challenges for Health Technology Assessments. The patient 11 (6) (2019)
Karen M Facey
As health technology assessment evolves so must its approach to patient involvement. Journal of comparative effectiveness research 8 (8) (2019)